Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DUQ78I
|
|||
| Drug Name |
RQNestin 34.5
|
|||
| Drug Type |
Oncolytic virus
|
|||
| Indication | Recurrent glioblastoma [ICD-11: 2A00.00; ICD-10: C71] | Phase 1 | [1] | |
| Company |
Candel Therapeutics Needham, MA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03152318) A Phase I Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2, a Genetically Engineered HSV-1 Virus, and Immunomodulation With Cyclophosphamide. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.